Cabot Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-19,520
Closed -$1.26M 151
2015
Q1
$1.26M Sell
19,520
-338
-2% -$21.2K 0.31% 91
2014
Q4
$1.17M Buy
19,858
+723
+4% +$40.8K 0.29% 92
2014
Q3
$979K Buy
19,135
+2,603
+16% +$130K 0.25% 99
2014
Q2
$802K Buy
16,532
+1,441
+10% +$71K 0.2% 102
2014
Q1
$784K Buy
15,091
+1,422
+10% +$75.7K 0.21% 110
2013
Q4
$727K Buy
13,669
+2,227
+19% +$113K 0.19% 119
2013
Q3
$530K Sell
11,442
-712
-6% -$31.3K 0.16% 123
2013
Q2
$543K Buy
+12,154
New +$528K 0.19% 140

Other funds holding BMY

Cabot Wealth Management's BMY Position: Q2 2015 in Review

Cabot Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q2 2015, closing a stake of 19,520 shares — an estimated $1.26M sold.

Cabot Wealth Management first reported a position in BMY in Q2 2013 and held it in 8 quarters. The position peaked at $1.26M in Q1 2015. 1,447 funds tracked by Wall St. Rank hold BMY as of Q2 2015.

  • Cabot Wealth Management reported no remaining Bristol-Myers Squibb position as of Q2 2015 after selling out during the quarter.
  • Cabot Wealth Management sold 19,520 Bristol-Myers Squibb shares in Q2 2015, an estimated $1.26M.
  • Cabot Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 8 quarters.
  • Cabot Wealth Management's Bristol-Myers Squibb position peaked at $1.26M in Q1 2015.
  • 1,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2015.

Based on Cabot Wealth Management's 13F filing for Q2 2015, filed 7 Aug 2015.